Axogen Inc (AXGN)
16.73
+0.47
(+2.89%)
USD |
NASDAQ |
Dec 26, 16:00
17.41
+0.68
(+4.06%)
After-Hours: 07:30
Axogen Research and Development Expense (Quarterly): 6.996M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Cutera Inc | 4.353M |
IRIDEX Corp | 1.299M |
Stereotaxis Inc | 2.454M |
Electromed Inc | 0.166M |
Myomo Inc | 1.249M |